WallStreetZenWallStreetZen

NASDAQ: PROF
Profound Medical Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PROF past revenue growth

How has PROF's revenue growth performed historically?
Company
10.99%
Industry
9.47%
Market
17.2%
PROF's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PROF's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PROF's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PROF earnings and revenue history

Current Revenue
$5.4M
Current Earnings
-$25.1M
Current Profit Margin
-463.6%

PROF Return on Equity

Current Company
-82%
Current Industry
10.5%
Current Market
188%
PROF's Return on Equity (-82%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PROF announces earnings.

PROF Return on Assets

Current Company
-62.9%
Current Industry
5.3%
PROF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PROF Return on Capital Employed

Current Company
-89.02%
Current Industry
8.3%
PROF's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PROF vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PROF$5.29M-$23.73M-$24.54M+22.94%N/A
SMLR$68.18M$24.70M$20.58M+25.98%+30.13%
MASS$50.23M-$34.03M-$36.40M+17.89%N/A
QIPT$182.44M$36.92M-$2.74M+125.88%N/A
INGN$315.66M-$84.19M-$102.45M-2.49%N/A
View Top Medical Device Stocks

PROF earnings dates

Next earnings date
May 15, 2024

Profound Medical Earnings & Revenue FAQ

What were PROF's earnings last quarter?

On Invalid Date, Profound Medical (NASDAQ: PROF) reported Q4 2023 earnings per share (EPS) of -$0.32, up 5.95% year over year. Total Profound Medical earnings for the quarter were -$10.31 million. In the same quarter last year, Profound Medical's earnings per share (EPS) was -$0.34.

If you're new to stock investing, here's how to buy Profound Medical stock.

What was PROF's earnings growth in the past year?

As of Q2 2024, Profound Medical's earnings has grown year over year. Profound Medical's earnings in the past year totalled -$24.54 million.

What is PROF's earnings date?

Profound Medical's earnings date is Invalid Date. Add PROF to your watchlist to be reminded of PROF's next earnings announcement.

What was PROF's revenue last quarter?

On Invalid Date, Profound Medical (NASDAQ: PROF) reported Q4 2023 revenue of $1.51 million up 64.63% year over year. In the same quarter last year, Profound Medical's revenue was $917.52 thousand.

What was PROF's revenue growth in the past year?

As of Q2 2024, Profound Medical's revenue has grown 10.99% year over year. This is 1.53 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Profound Medical's revenue in the past year totalled $5.29 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.